People with cardiometabolic disorders—such as obesity, diabetes and heart disease—could increase their chances of living longer by adopting a healthy plant-based diet, according to a study being ...

Earn continuing education credits Prepare for initial and continuous certification Stay current with the latest clinical science and guidelines Connect with peers through meetings, events and ...

This page features ACC's coverage of the latest science from ESC Congress 2024 – Aug. 30th through Sept. 2nd – including trial summaries, news stories and more.

Patients with symptomatic nonobstructive hypertrophic cardiomyopathy (HCM) who were treated with aficamten vs. placebo saw significantly greater improvement in exercise capacity and self-reported ...

Health care professionals should explore the use of glucagon-like peptide-1 receptor agonists (GLP1RAs) for cardiovascular risk reduction and their broader impacts on cardiometabolic health beyond ...

Patients with transthyretin amyloidosis with cardiomyopathy (ATTR-CM) who were treated with eplontersen, a once-monthly transthyretin gene silencer, experienced no significant difference in ...

The ACC is dedicated to creating a strong, diverse and inclusive field of future cardiovascular physicians, scientists and professionals. The ACC's Internal Medicine and Pediatric Cardiology Program ...

Silent atherosclerosis is detectable using imaging in early adulthood, with age- and sex-associated increases in prevalence across arterial territories and significant increases in plaque volume, ...

The U.S. Food and Drug Administration (FDA) has approved baxdrostat, a first-in-class oral aldosterone synthase inhibitor, as an add-on therapy for hypertension in adults whose blood pressure (BP) is ...

Inflammation plays a central role in the pathogenesis of atherosclerosis and cardiovascular disease. 1 Atherosclerosis in particular is an inflammatory process that involves endothelial dysfunction, ...

Pulmonary-artery denervation, in addition to guideline-directed medical therapy, resulted in fewer events of clinical worsening than medical therapy alone in patients with pulmonary hypertension ...

Researchers presenting findings from the AIR-STEMI trial at ESC Congress 2026 said a strategy of complete coronary artery revascularization guided by functional coronary angiography resulted in a ...